Abstract

Human type 1 diabetes (T1D) is considered to be an autoimmune disease, with CD8+ T-cell-mediated cytotoxicity being directed against the insulin-producing beta cells, leading to a gradual decrease in beta cell mass and the development of chronic hyperglycemia. The histopathologically defining lesion in recent-onset T1D patients is insulitis, a relatively subtle leucocytic infiltration present in approximately 10 % of the islets of Langerhans from children with recent-onset (<1 year) disease. Due to the transient nature of the infiltrate, its heterogeneous distribution in the pancreas and the nature of the patient population, material for research is extremely rare and limited to a cumulative total of approximately 150 cases collected over the past century. Most studies on the etiopathogenesis of T1D have therefore focused on the non-obese diabetic (NOD) mouse model, which shares many genetic and immunological disease characteristics with human T1D, although its islet histopathology is remarkably different. In view of these differences and in view of the limited success of clinical immune interventions based on observations in the NOD mouse, there is a renewed focus on studying the pathogenetic process in patient material.

Highlights

  • Human type 1 diabetes (T1D) is considered to be an autoimmune disease, with CD8+ T-cell-mediated cytotoxicity being directed against the insulin-producing beta cells, leading to a gradual decrease in beta cell mass and the development of chronic hyperglycemia

  • The presence of autoantibodies is usually taken as a sign of ongoing beta cell destruction, with beta cell mass decreasing as autoimmunity expands as witnessed by the increasing number of autoantibodies

  • From a histopathological point of view, the insulitic lesions in the islet of Langerhans of recent-onset T1D patients are very different from those observed in the nonobese diabetic (NOD) mouse

Read more

Summary

The discovery of insulitis

Insulitis is defined as a predominantly lymphocytic infiltration, limited to the islets of Langerhans. In a 1978 follow-up study [23], using the newly developed immunohistochemical staining techniques for islet hormones, he observed that insulitis preferentially targeted islets with remaining beta cells and that it was virtually absent in islets from which the beta cells had disappeared This led him to propose that ‘insulitis represents an immune reaction of the delayed type, directed against beta cells’. His studies were confirmed by Foulis [24], who used a computerized survey of deaths in the UK and was able to retrieve tissue blocks of 119 patients who died in diabetic ketoacidosis before the age of 20. Major follow-up studies have been lacking due to the reasons outlined above, and only recently a renewed effort to study insulitis in human T1D was initiated using large biobanks of human donor pancreas in Brussels and Gainesville-FL (JDRF-nPOD)

Phenotyping insulitis
Insulitis in the preclinical phase
Insulitis is frequent in young patients
Duration of disease
Normal islets are frequent after clinical onset
Insulitis in the NOD mouse
Stages of diabetes development in the NOD mouse
Comparing insulitis in human disease with the NOD mouse model
Immunophenotyping of insulitis shows similarities
Early stages of insulitis are associated with beta cell replication
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call